{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:49:40Z","timestamp":1775278180612,"version":"3.50.1"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.2169\/internalmedicine.6071-25","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T22:08:17Z","timestamp":1755727697000},"page":"1064-1068","source":"Crossref","is-referenced-by-count":0,"title":["Methotrexate-Associated Systemic Lymphadenopathy Exhibiting a Marked Elevation of the Serum IgG4 Concentrations"],"prefix":"10.2169","volume":"65","author":[{"given":"Yasuhiro","family":"Masuta","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Omaru","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Minaga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Honjo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Harigai M. Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective. Mod Rheumatol 28: 1-8, 2018.","DOI":"10.1080\/14397595.2017.1352477"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tokuhira M, Saito S, Suzuki K, et al. Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders. Leuk Lymphoma 60: 2508-2515, 2019.","DOI":"10.1080\/10428194.2019.1585841"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rizzi R, Curci P, Delia M, et al. Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 26: 1-9, 2009.","DOI":"10.1007\/s12032-008-9069-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Tokuhira M, Tanaka Y, Takahashi Y, et al. The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders. J Clin Exp Hematop 60: 41-50, 2020.","DOI":"10.3960\/jslrt.19039"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Saito S, Kaneko Y, Yamaoka K, Tokuhira M, Takeuchi T. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate. Rheumatology (Oxford) 56: 940-946, 2017.","DOI":"10.1093\/rheumatology\/kex002"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglobulin G4: an odd antibody. Clin Exp Allergy 39: 469-477, 2009.","DOI":"10.1111\/j.1365-2222.2009.03207.x"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet 385: 1460-1471, 2015.","DOI":"10.1016\/S0140-6736(14)60720-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Watanabe T, Minaga K, Kamata K, Kudo M, Strober W. Mechanistic insights into autoimmune pancreatitis and IgG4-related disease. Trends Immunol 39: 874-889, 2018.","DOI":"10.1016\/j.it.2018.09.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hamed KM, Dighriri IM, Baomar AF, et al. Overview of methotrexate toxicity: a comprehensive literature review. Cureus 14: e29518, 2022.","DOI":"10.7759\/cureus.29518"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lin G, Li J. Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int 30: 837-840, 2010.","DOI":"10.1007\/s00296-009-1330-8"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Maslinska M, Dmowska-Chalaba J, Jakubaszek M. The role of IgG4 in autoimmunity and rheumatic diseases. Front Immunol 12: 787422, 2021.","DOI":"10.3389\/fimmu.2021.787422"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zhao Z, Hua Z, Luo X, et al. Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150: 113074, 2022.","DOI":"10.1016\/j.biopha.2022.113074"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Arai Y, Yamashita K, Kuriyama K, et al. Plasmacytoid dendritic cell activation and IFN-alpha production are prominent features of murine autoimmune pancreatitis and human IgG4-related autoimmune pancreatitis. J Immunol 195: 3033-3044, 2015.","DOI":"10.4049\/jimmunol.1500971"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Omaru N, Otsuka Y, Hara A, et al. Microbe-associated molecular patterns derived from fungi and bacteria promote IgG4 antibody production in patients with type 1 autoimmune pancreatitis. Cytokine 183: 156748, 2024.","DOI":"10.1016\/j.cyto.2024.156748"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Watanabe T, Yamashita K, Arai Y, et al. Chronic fibro-inflammatory responses in autoimmune pancreatitis depend on IFN-alpha and IL-33 produced by plasmacytoid dendritic cells. J Immunol 198: 3886-3896, 2017.","DOI":"10.4049\/jimmunol.1700060"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kameda T, Nakashima S, Mitamura K, et al. FDG-PET\/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis. Sci Rep 12: 15367, 2022.","DOI":"10.1038\/s41598-022-19727-y"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Katsuyama T, Sada KE, Yan M, et al. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents. Mod Rheumatol 27: 773-777, 2017.","DOI":"10.1080\/14397595.2016.1259714"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Shiokawa M, Kodama Y, Kuriyama K, et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut 65: 1322-1332, 2016.","DOI":"10.1136\/gutjnl-2015-310336"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shiokawa M, Kodama Y, Sekiguchi K, et al. Laminin 511 is a target antigen in autoimmune pancreatitis. Sci Transl Med 10: eaaq0997, 2018.","DOI":"10.1126\/scitranslmed.aaq0997"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hubers LM, Vos H, Schuurman AR, et al. Annexin A11 is targeted by IgG4 and IgG1 autoantibodies in IgG4-related disease. Gut 67: 728-735, 2018.","DOI":"10.1136\/gutjnl-2017-314548"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tsuge S, Mizushima I, Horita M, et al. High serum IgA levels in patients with IgG4-related disease are associated with mild inflammation, sufficient disease-specific features, and favourable responses to treatments. Mod Rheumatol 34: 621-631, 2024.","DOI":"10.1093\/mr\/road056"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Della-Torre E, Campochiaro C, Bozzolo EP, et al. Methotrexate for maintenance of remission in IgG4-related disease. Rheumatology (Oxford) 54: 1934-1936, 2015.","DOI":"10.1093\/rheumatology\/kev244"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_6071-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T03:55:30Z","timestamp":1775274930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/7\/65_6071-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6071-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"6071-25"}}